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Abst ract
Background and purpose: Diabetes mellitus (DM) is an in -
dependent risk factor for cardiovascular diseases. The origin
of diabetic microangiopathy is multifactorial; it affects all lay-
ers of the artery wall, causing endothelial and vasoreactivity
impairment. The incidence of cerebral vasoreactivity failure
in diabetic patients without stroke history is not precisely de -
termined yet. The aim of the study was to assess the cere-
brovascular reactivity in hypocapnia and hypercapnia in
patients with type 2 DM with or without arterial hyperten-
sion without artery stenosis and stroke history, with the use
of transcranial Doppler examination.
Material and methods: The mean blood flow velocity, pul-
satility index and parameters of cerebrovascular reactivity were
measured in 53 patients with type 2 DM (aged 42-72 years,
mean 59.5 ± 7.9) and in 27 healthy volunteers (aged 36-
74 years, mean 57.0 ± 10.4). Diabetics were further divid-
ed into two subgroups according to the presence or absence
of arterial hypertension.
Results: The index of cerebrovascular reactivity in hypocap-
nia and hypercapnia was significantly worse and time need-
ed to normalization of blood flow velocity was significantly
longer in patients with DM in comparison with healthy vo -
lunteers. 
Cerebral vasoreactivity in hypocapnia and hypercapnia in patients 
with diabetes mellitus type 2 with or without arterial hypertension
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St reszc zenie
Wstêp i cel pracy: Cukrzyca to niezale¿ny czynnik ryzyka roz-
woju chorób uk³adu naczyniowego. Pochodzenie cukrzycowej
angio patii jest wieloczynnikowe. Nie okreœlono dot¹d dok³adnie
czêstoœci wystêpowania upoœledzenia reakcji wazoaktywnych
u chorych na cukrzycê typu 2 bez incydentów udarowych w wy -
wiadzie. Celem pracy by³o zbadanie przy u¿yciu przezczasz-
kowej ultrasonografii prêdkoœci œredniej przep³ywu krwi,
wspó³czynnika pulsacji oraz parametrów reaktywnoœci naczyñ
mózgowych w warunkach hipokapnii i hiperkapnii u chorych
na cukrzycê typu 2 z nadciœnieniem têtniczym lub bez nadciœ -
nienia têtniczego bez ultrasonograficznych cech zwê¿eñ têtnic
szyjnych i mózgowych oraz nieobci¹¿onych udarem mózgu.
Materia³ i metody: Badania wykonano u 53 chorych (27 kobiet
i 26 mê¿czyzn) w wieku od 42 do 72 lat (œrednia wieku 59,5 ±
7,9 roku) z cukrzyc¹ typu 2. Wœród chorych wydzielono pod-
grupy z nadciœnieniem têtniczym i bez nadciœnienia. Grupê 
kontroln¹ stanowi³o 27 ochotników w wieku 36–74 lat (œrednia
wieku 57,0 ± 10,4 roku). U wszystkich przeprowadzono bada-
nie dopplerowskie têtnic szyjnych i mózgowych oraz oznaczo-
no wspó³czynnik reaktywnoœci naczyñ mózgowych w warun-
kach hipokapnii i hiperkapnii. 
Wyniki: W hipokapnii i hiperkapnii u chorych na cukrzy-
cê typu 2 stwierdzono istotnie mniejsze wspó³czynniki reak-
tywnoœci naczyñ mózgowych oraz znamiennie d³u¿szy czas
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Introduction
Cerebral microangiopathy is one of the major causes
of cerebrovascular events in patients with type 2 diabetes
mellitus (DM). The small arteries in those patients 
feature thickened basement membrane, proliferation of
endo thelial cells, and abnormal collagen structure with-
in the tunica externa [1].
The origin of diabetic angiopathy is multifactorial
and should be viewed in the context of the changes in
gene expression, hormonal and metabolic abnormalities,
coexistent insulin resistance and the predisposition to
arterial hypertension [2]. The early stages of microan-
giopathy include a period of structural adaptation and
remodelling of the vessel wall, followed by damage to
all layers of the vessel wall, including endothelium.
Changes in the architecture of the walls both in large
and small cerebral arteries in DM suggest the presence
of disordered reactivity of those vessels as the result of
endothelial and tunica media dysfunction.
Increased or decreased blood flow velocities within
the arteries at the base of the brain, as well as the changes
in vessel reactivity, as recorded with the ultrasound
Doppler study, might be considered as an index of the
occurrence of diabetic microangiopathy [3-6]. Even in
the early stages of the disease, capillaries show functional
changes, i.e. increased blood flow, increased intravas-
cular pressure, increased permeability and endothelial
dysfunction [2,7]. Abnormalities of cerebral vessel reac-
tivity might be important for the increased risk of cere-
brovascular events in diabetic patients; they could also
serve as an indicator of the severity of changes within
the cerebral arteries [8-11].
The aim of the study was to assess the cerebrovas-
cular reactivity indexes in hypocapnia and hypercapnia
among patients with type 2 DM with or without arte -
rial hypertension, who had neither carotid or coronary
artery stenosis nor stroke history, i.e. in patients without
clinical manifestation of small vessel disease.
Material and methods
This study initially recruited 95 subjects but 15 of
them were excluded because of the poor transparency 
of the ultrasonographic temporal bone windows, due to
stenosis within the carotid arteries or due to significant
(> 15%) asymmetry of the blood flow velocity between
the respective arteries on both sides.
Finally, the study was conducted in 53 patients 
(27 women and 26 men), aged between 42 and 72
(mean 59.5 ± 7.9) and diagnosed with type 2 DM
according to the criteria proposed by the American Dia-
betes Association (1997) and by the World Health
Organization (WHO, 1999).
Twenty-one patients (40%) had arterial hyperten-
sion. All diabetic patients (mean disease duration 7 ±
1.6 years) had good glycaemic control, as suggested by
the daily measurements of fasting and postprandial blood
glucose registered in 3-month diaries.
Inclusion criteria were: (1) diagnosis of type 2 DM,
(2) no current or previous symptoms or signs sugges-
tive of focal brain damage (stroke, transient ischaemic
attack, reversible ischaemic neurological deficit); (3) no
current or previous serious head trauma or any other
disease of the central nervous system; (4) age between
35 and 75 years; and (5) lack of significant technical dif-
ficulties during the testing.
We excluded patients who: (1) had stenosis or occlu-
sion of carotid or intracranial arteries in Doppler study;
(2) had migraine or other vascular headaches; (3) chro-
nically used non-steroid antiinflammatory drugs, ni -
trates, or hormonal replacement therapy; (4) had lesion(s)
typi cal for ischaemic lesions in magnetic resonance imag-
ing (MRI), except for the lacunae; (5) were smokers;
(6) had altered consciousness; (7) reported maximal val-
ues of systolic blood pressure > 200 mm Hg or dias-
tolic blood pressure > 100 mm Hg; (8) were diagnosed
with respiratory, renal, heart or liver failure; (9) were
addicted to alcohol.
Conclusions: Most DM type 2 patients without stroke his-
tory had decreased values of cerebral vasoreactivity parame-
ters, which suggests the presence of microangiopathy.
Key words: cerebral vasoreactivity, diabetes mellitus, hypocap-
nia, hypercapnia.
normalizacji prêdkoœci przep³ywu krwi w prawej têtnicy œrod-
kowej mózgu w stosunku do grupy kontrolnej.
Wnioski: U znacznej czêœci chorych na cukrzycê typu 2 bez
incydentów niedokrwienia mózgu w wywiadzie wystêpuj¹
w hipokapnii i hiperkapnii mniejsze wartoœci parametrów reak-
tywnoœci naczyñ mózgowych, mog¹ce sugerowaæ obecnoœæ
mikroangiopatii. 
S³owa kluczowe: reaktywnoœæ naczyñ mózgowych, cukrzyca,
hipokapnia, hiperkapnia.
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Participants were instructed neither to drink coffee,
nor to take their regular medications, except for hypoten-
sive drugs.
The control group consisted of 27 non-smoking vo-
lunteers (12 women and 15 men), aged between 36 and
74 (mean 57.0 ± 10.4) with back pain syndromes but
without a history of DM, arterial hypertension, other
cardiovascular diseases or cerebrovascular events. Mean
age of patients and controls was similar (p= 0.236).
All participants were informed about the aim of the
study and its procedures. They gave informed consent
to participate. The study protocol was accepted by 
the Bioethical Committee at the Silesian Medical Uni-
versity of Katowice (no. NN-013-215/03).
Before the Doppler study, blood pressure and heart
rate were measured. Further procedures were only per-
formed in patients whose systolic blood pressure was 
120-135 mm Hg, diastolic blood pressure was 70-
85 mm Hg, and heart rate was 68-80 per minute.
During the first part of the procedure, mean blood
flow velocity (Vmean) expressed in centimetres per se -
cond, as well as the Gosling pulsatility index (PI), were
measured in common, internal and external carotid arter-
ies (CCA, ICA and ECA, respectively), vertebral, basi-
lar, anterior cerebral, middle cerebral and posterior cere-
bral arteries. Measurements were made in the supine
position, except for the vertebrobasilar system assess-
ment which was made in a sitting position. Blood flow
parameters were assessed according to the criteria propos -
ed by Demchuk et al. [12,13]. Interhemispheric diffe -
ren ces for Vmean and PI did not exceed 15%.
The measurements were made once with the Pioneer
TC 2020 (EME) apparatus with pulsating probes of
2 and 4 MHz. All procedures were performed in the
morning, by the same investigator, which guaranteed 
the reproducibility of the results (intraobserver agreement
was 0.73 in the group of 40 persons) (MedCalc Statisti-
cal Software v.12.1.1). So-called blind Doppler was used
rather than the duplex examination to detect possible sig-
nificant stenoses that might have significantly affected 
the blood flow in cerebral arteries. 
The second stage of the examination involved evalu-
ation of the cerebral vasoreactivity index during hypo -
capnia and hypercapnia, using previously published me -
tho dological standards [14-17].
The measurements of vasoreactivity were performed
within the right middle cerebral artery, as no significant
difference of blood flow velocity was found between sides.
Vasoreactivity indexes were calculated from the equa-
tion proposed by Kastrup and adapted for hypocapnia
and hypercapnia conditions [14]:
(Vmean N – Vmean H) × 100% Reactivity index = ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Vmean N × (∆pCO2) [%/mm Hg]
Where Vmean N indicates mean velocity within the
right middle cerebral artery in normocapnia, Vmean H
indicates mean velocity within the right middle cerebral
artery in either hyper- or hypocapnia, and ∆pCO2 is 
the difference between end-tidal partial pressure of CO2
in hypo/hypercapnia and normocapnia conditions.
Hypocapnia was induced by 3-minute hyperventila-
tion following 3-minute resting. The measurements of
end-tidal CO2 partial pressure and the level of arterial
blood saturation were made with the capnograph. Hypo -
capnia was defined as the end-tidal CO2 partial pressure
of 15-30 mm Hg corresponding to the same partial pres-
sure interval in blood. The cerebrovascular reactivity index
was assessed in the third minute of hyperventilation.
After a 3-minute rest period, hypercapnia was induced
with 2-minute ventilation in a closed circuit with gas con-
taining 95% air and 5% CO2 given through an anaes-
thetic mask connected with the gas reservoir. Hypercap-
nia was defined as the end-tidal CO2 partial pressure of
45-60 mm Hg corresponding to the same partial pres-
sure interval in blood. The cerebrovascular reactivity index
was assessed in the first minute after the 2-minute venti-
lation with the gas of increased CO2 concentration.
End-tidal CO2 partial pressure was assessed with
a capnograph (COSMO 2, Novametrix) with the sensor
mounted on the special tube used by the participants for
breathing with closed nostrils. Pulse oximetry was used
to measure the saturation of the arterial blood. Blood
flow parameters were calculated as means of the read-
ings made within three cardiac cycles.
Additionally, the time needed for the normalization
of the Vmean obtained in hypo- or hypercapnia was calcu -
lated. 
Mean 3-month glycaemia was calculated using the
data stored in diaries completed by diabetic patients. It
was similar between patients with and without arterial
hypertension.
Descriptive statistics (means, medians, quartiles, stan-
dard deviations) and the analysis of statistical significan -
ce of differences were performed with STATISTICA
v.7 PL (StatSoft). Distribution of each analysed vari-
able was tested with the Shapiro-Wilk test. As those dis-
tributions deviated significantly from the normal one,
the non-parametric Mann-Whitney U-test was used for
comparisons between groups. P-values of less than 0.05
were considered statistically significant.
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Results
Normocapnia conditions
Blood flow velocity in the right middle cerebral ar -
tery in normocapnia (median, 48 [interquartile range,
42-54] cm/s) in patients with type 2 DM did not differ
from that in controls (51 [48-55] cm/s). It was also simi -
lar in the subgroup of diabetic patients without arterial
hypertension (50 [43-56] cm/s) and in diabetic patients
with arterial hypertension (48 [42-50] cm/s).
PI in diabetic patients without hypertension (0.97
[0.83-1.05]) and in diabetics with hypertension (0.99
[0.79-1.05]) was significantly higher than in controls
(0.85 [0.78-0.98], p= 0.041 and 0.0205, respectively).
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Variable Patients with Controls P-value
diabetes mellitus
Mean velocity [cm/s]
Hypocapnia 35.5 (28.0-38.5) 33.0 (30.0-36.0) NS
Hypercapnia 65.5 (56.5-76.0) 73.0 (70.0-80.0) 0.0446
Pulsatility index
Hypocapnia 1.30 (1.19-1.62) 1.20 (0.90-1.50) NS
Hypercapnia 0.77 (0.69-0.87) 0.71 (0.68-0.80) NS
Cerebral vasoreactivity index [%/mm Hg]
Hypocapnia 2.58 (2.08-2.90) 3.53 (3.27-3.78) 0.0000
Hypercapnia 3.43 (2.58-4.07) 4.50 (3.74-5.21) 0.0002
Time needed for parameters’ normalization [s]
Hypocapnia 2.00 (1.43-2.65) 1.20 (0.90-1.50) 0.0004
Hypercapnia 0.50 (0.38-0.82) 0.25 (0.25-0.35) 0.0000
Table 1. Comparison of blood flow parameters in right middle cerebral artery in patients with type 2 diabetes mellitus without arterial hypertension with the control
group in hypo- and hypercapnia (values are presented as medians with interquartile range)
NS – non-significant




Hypocapnia 33.0 (31.0-38.0) 33.0 (30.0-36.0) NS
Hypercapnia 61.0 (53.0-71.0) 73.0 (70.0-80.0) 0.0063
Pulsatility index
Hypocapnia 1.39 (1.27-1.64) 1.20 (0.90-1.50) 0.0205
Hypercapnia 0.78 (0.68-0.84) 0.71 (0.68-0.80) NS
Cerebral vasoreactivity index [%/mm Hg]
Hypocapnia 2.50 (1.90-2.90) 3.53 (3.27-3.78) 0.0000
Hypercapnia 2.77 (1.78-3.86) 4.50 (3.74-5.21) 0.0000
Time needed for parameters’ normalization [s]
Hypocapnia 2.30 (2.10-3.00) 1.20 (0.90-1.50) 0.0000
Hypercapnia 0.60 (0.50-1.00) 0.25 (0.25-0.35) 0.0000
Table 2. Comparison of blood flow parameters in right middle cerebral artery in patients with diabetes mellitus and arterial hypertension with the control group 
in hypo- and hypercapnia (values are presented as medians with interquartile range)
NS – non-significant
Neurologia i Neurochirurgia Polska 2012; 46, 6 533
Cerebral vasoreactivity in hypocapnia and hypercapnia in diabetic patients
Hypocapnia conditions
Diabetic patients both with (p= 0.0004) and with-
out arterial hypertension (p< 0.0001) had longer time
needed for normalization of the blood flow velocity in
the right middle cerebral artery in comparison to con-
trols. The cerebrovascular reactivity index was lower in
diabetic patients (with or without arterial hypertension)
than in the control group (p = 0.0000). Blood flood
velocity in the right middle cerebral artery, PI and cere-
brovascular reactivity indexes were all within the normal
range in patients and controls (Tables 1 and 2).
Normal values of the cerebrovascular reactivity index
found in this study in hypocapnia conditions were
between 3.27 and 3.78%/mm Hg (interquartile range).
Hypercapnia conditions
Blood flow velocity in the right middle cerebral arte -
ry was lower in diabetic patients with hypertension
(p= 0.0063) or without hypertension (p= 0.0446) than
in controls. Diabetic patients both with and without
arterial hypertension had longer time needed for norma -
lization of the blood flow velocity in the right middle cere-
bral artery in comparison to controls (both p < 0.0001).
The cerebrovascular reactivity index was lower in dia-
betic patients (with or without arterial hypertension) than
in the control group (p< 0.0001 and p= 0.0002, respec-
tively). Blood flood velocity in the right middle cerebral
artery, PI and cerebrovascular reactivity indexes were 
all within the normal range in patients and controls, sim-
ilarly to the hypocapnia conditions (Tables 1 and 2).
Normal values of the cerebrovascular reactivity index
found in this study in hypercapnia conditions were
between 3.74 and 5.21%/mm Hg (interquartile range).
Discussion
Transcranial Doppler ultrasonography enables mea-
surements of the blood flow velocity in cerebral arteries
and the registration of blood flow changes during pro -
vocative tests. It helps therefore to assess the ability of
cerebral vessels to react to the changing partial pressures
of CO2. According to the experimental studies, de -
creased reactivity suggests abnormalities within the ves-
sel wall [3].
The goal of the present study was to assess the cere-
brovascular reactivity changes in patients with type 2 DM
before the clinical manifestation of the focal brain is -
chaemia.
About 40% of studied patients had arterial hyper-
tension, which itself predisposes to the microangiopathic
changes. Patients with type 2 DM were therefore divid-
ed into two subgroups: those with and without arterial
hypertension.
Diabetic patients without arterial hypertension had
higher PI values than healthy controls. PI increases in
case of increased peripheral vascular resistance, locally
before the site of major stenosis or occlusion, and gene -
rally in small vessel disorders [18,19].
Increased PI was noted in patients in whom the ste -
nosis or occlusion of the extra- or intracranial arteries
was a priori excluded. It therefore reflects increased vas-
cular resistance due to the vessel wall remodelling in
arterioles. Hence, these results may reflect the presence
of abnormalities within the arteriole walls and suggest
that type 2 DM might be an independent risk factor for
the cerebral microangiopathy.
Lee et al. [18] found an increased mean PI value in
the internal carotid artery and middle cerebral artery in
patients with type 2 DM who had diabetic complications
(retinopathy, nephropathy, neuropathy), while in diabe -
tics without clinical manifestation of the microangio-
pathy, PI values were similar to those obtained in healthy
subjects. Lippera et al. [3] used transcranial Doppler to
study blood flow parameters in anterior and middle cere-
bral arteries, as well as in ophthalmic arteries, and also
noted an increased PI in patients without a history of
neurological events, who had microangiopathy in extra -
cerebral vessels. Those authors suggested the existence
of latent diabetic cerebral microangiopathy.  
Hypocapnia physiologically leads to vasoconstriction
which manifests with decreased blood flow velocity and
increased PI. The attenuated vasoconstriction in response
to hypocapnia is probably associated with the structural
changes of the vessel wall that also result in dysfunction
of endothelin-1 (ET-1) release, which is the major me -
diator of the vasoconstriction in hypocapnia [20].
Kanno et al. [21] and Smulders et al. [22] reported
decreased serum ET-1 concentrations in patients with
type 1 and type 2 DM. Similarly, Vazquez et al. [23] ob-
served decreased ET-1 levels in patients with type 1
DM and with subclinical regional cerebral hypoperfu-
sion, as assessed with SPECT.
Abnormal vasoconstrictive responses in DM might
also be related to receptor dysregulation, altered sensi-
tivity to CO2, as well as to the lower compliance of the
vessel wall. The role of the sympathetic innervation in
direct and indirect regulation of muscle tone within the
vessel wall should also be considered.
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The present study also showed that patients with
type 2 DM and without arterial hypertension additio -
nally feature very slow normalization of the blood flow
parameters after the resolution of hypocapnia. This find-
ing has not been reported previously, and the mecha-
nism of such a response is unclear. It is possible that this
blunted response is due to the insufficient compensatory
mechanism that reverses the decreased blood flow in
hypocapnia, i.e. the action of the vasodilators. The atten-
uated vasoconstriction of the arterioles and the prolonged
time of their return to baseline in patients with type 2 DM
might suggest damage of the vessel wall, i.e. the pres-
ence of microangiopathy.
Hypercapnia physiologically leads to vasodilation,
which manifests with increased blood flow velocity and
decreased PI. We found that the increase of that veloc-
ity, as well as its final value, was lower in patients with
type 2 DM and without arterial hypertension than in
healthy subjects.
Dandona et al. [24] and Fulesdi et al. [25] observed
a smaller increase of the average mean velocity in hyper-
capnia and decreased parameters of vascular reactivity
in patients with type 1 DM, while Tantucci et al. [26]
reported similar observations in patients both with type 1
and with type 2 DM. The authors highlight the role of
autonomic neuropathy in the attenuation of the vasodila-
tory response to increased partial pressure of CO2. De -
creased reactivity index values in patients with type 1
DM were also reported by Kozera et al. [27].
Our patients with type 2 DM, when compared to
the healthy subjects, had significantly prolonged time
needed for normalization of parameters after hypercap-
nia. Its mechanism is also unclear but it possibly results
from the abnormal compensation reactions, similarly to
the same finding in hypocapnia.
Our findings support the presence of attenuated
vasoactive responses to the chemical stimulus in patients
with type 2 DM, which may suggest that the disease is
an independent factor influencing the ability of cerebral
arteries to constrict and to dilate.
Given the fact that the attenuated vasoactive respons-
es might reflect structural or humoral insufficiency of
the cerebral arterioles, it may be suspected that subcli -
nical cerebral microangiopathy is quite prevalent among
patients with type 2 DM. Blood flow parameters among
the studied diabetic patients were within the normal
range in the majority of cases, although they differ sig-
nificantly from those obtained in the healthy subjects. It
is worth noting that those patients had neither previous
clinical episodes of brain ischaemia nor signs of focal
damage to the central nervous system.
Attenuated reactivity of the cerebral vessels in those
patients raises the suspicion that despite the lack of signs
of central nervous system damage, some of those patients
may actually have a dysfunction of the cerebral arterio -
les, which probably reflects damage of the vessel wall
and points to the risk of clinical events of cerebral is -
chaemia.
Limitations of the present study include the relatively
small study sample, which resulted from the difficulties
in recruitment of diabetic patients who fulfil the other
i nclusion criteria. The other limitation was the single
examination of cerebrovascular reactivity; multiple exa -
mi nations with the averaging of results might better
reflect the values of the studied parameters.
Conclusions
The majority of DM type 2 patients without stroke
history had decreased values of cerebral vasoreactivity
parameters, which suggests the presence of microan-
giopathy.
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